Pfizer (PFE) Presents Encouraging New Data for INLYTA Combo Phase 1b in Adv. RCC
Go back to Pfizer (PFE) Presents Encouraging New Data for INLYTA Combo Phase 1b in Adv. RCC| Merck & Co. (NYSE: MRK) | Delayed: 130.72 +3.72 (2.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $127.00 | 52 Week High | $65.46 | |||
| Open | $129.69 | 52 Week Low | $47.97 | |||
| Day High | $132.80 | P/E | 88.93 | |||
| Day Low | $128.76 | EPS | $1.47 | |||
| Volume | 12,755,225 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.26 -1.01 (3.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.27 | 52 Week High | $37.39 | |||
| Open | $26.27 | 52 Week Low | $28.25 | |||
| Day High | $26.43 | P/E | 15.31 | |||
| Day Low | $25.25 | EPS | $1.65 | |||
| Volume | 47,643,116 | |||||
